Industry Research Reports
Global Lenalidomide API Market Research Report 2024
Industry: Chemical & Material
Published Date: 2024-01-10
Pages: 85 Pages
Report ld: 2404683
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
The global Lenalidomide API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lenalidomide API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lenalidomide API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lenalidomide API include Dr. Reddy’s Laboratories Ltd., Johnson Matthey PLC, Changzhou Pharmaceutical Factory, Shilpa Medicare Limited, Biocon Limited, Sun Pharmaceutical Industries Ltd., Shenzhen Haorui and Mac-Chem Products (India) Pvt.Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lenalidomide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lenalidomide API.
MARKET SEGMENTATION
By Company
- Dr. Reddy’s Laboratories Ltd.
- Johnson Matthey PLC
- Changzhou Pharmaceutical Factory
- Shilpa Medicare Limited
- Biocon Limited
- Sun Pharmaceutical Industries Ltd.
- Shenzhen Haorui
- Mac-Chem Products (India) Pvt.Ltd
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity≥98%
- Purity<98%
Segment by Application
- Lenalidomide capsules
- Others
REPORT SCOPE
The Lenalidomide API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lenalidomide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lenalidomide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lenalidomide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Lenalidomide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Lenalidomide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Lenalidomide API Market Overview
1.1 Product Definition
1.2 Lenalidomide API Segment by Type
1.2.1 Global Lenalidomide API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Lenalidomide API Segment by Application
1.3.1 Global Lenalidomide API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Lenalidomide capsules
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Lenalidomide API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Lenalidomide API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Lenalidomide API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Lenalidomide API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Lenalidomide API Production Market Share by Manufacturers (2019-2024)
2.2 Global Lenalidomide API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Lenalidomide API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Lenalidomide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Lenalidomide API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Lenalidomide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Lenalidomide API, Product Offered and Application
2.8 Global Key Manufacturers of Lenalidomide API, Date of Enter into This Industry
2.9 Lenalidomide API Market Competitive Situation and Trends
2.9.1 Lenalidomide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Lenalidomide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Lenalidomide API Production by Region
3.1 Global Lenalidomide API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Lenalidomide API Production Value by Region (2019-2030)
3.2.1 Global Lenalidomide API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Lenalidomide API by Region (2025-2030)
3.3 Global Lenalidomide API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Lenalidomide API Production by Region (2019-2030)
3.4.1 Global Lenalidomide API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Lenalidomide API by Region (2025-2030)
3.5 Global Lenalidomide API Market Price Analysis by Region (2019-2024)
3.6 Global Lenalidomide API Production and Value, Year-over-Year Growth
3.6.1 India Lenalidomide API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Lenalidomide API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Lenalidomide API Production Value Estimates and Forecasts (2019-2030)
4 Lenalidomide API Consumption by Region
4.1 Global Lenalidomide API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Lenalidomide API Consumption by Region (2019-2030)
4.2.1 Global Lenalidomide API Consumption by Region (2019-2024)
4.2.2 Global Lenalidomide API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Lenalidomide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Lenalidomide API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Lenalidomide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Lenalidomide API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Lenalidomide API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Lenalidomide API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Lenalidomide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Lenalidomide API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Lenalidomide API Production by Type (2019-2030)
5.1.1 Global Lenalidomide API Production by Type (2019-2024)
5.1.2 Global Lenalidomide API Production by Type (2025-2030)
5.1.3 Global Lenalidomide API Production Market Share by Type (2019-2030)
5.2 Global Lenalidomide API Production Value by Type (2019-2030)
5.2.1 Global Lenalidomide API Production Value by Type (2019-2024)
5.2.2 Global Lenalidomide API Production Value by Type (2025-2030)
5.2.3 Global Lenalidomide API Production Value Market Share by Type (2019-2030)
5.3 Global Lenalidomide API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Lenalidomide API Production by Application (2019-2030)
6.1.1 Global Lenalidomide API Production by Application (2019-2024)
6.1.2 Global Lenalidomide API Production by Application (2025-2030)
6.1.3 Global Lenalidomide API Production Market Share by Application (2019-2030)
6.2 Global Lenalidomide API Production Value by Application (2019-2030)
6.2.1 Global Lenalidomide API Production Value by Application (2019-2024)
6.2.2 Global Lenalidomide API Production Value by Application (2025-2030)
6.2.3 Global Lenalidomide API Production Value Market Share by Application (2019-2030)
6.3 Global Lenalidomide API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories Ltd.
7.1.1 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Corporation Information
7.1.2 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Product Portfolio
7.1.3 Dr. Reddy’s Laboratories Ltd. Lenalidomide API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
7.2 Johnson Matthey PLC
7.2.1 Johnson Matthey PLC Lenalidomide API Corporation Information
7.2.2 Johnson Matthey PLC Lenalidomide API Product Portfolio
7.2.3 Johnson Matthey PLC Lenalidomide API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Johnson Matthey PLC Main Business and Markets Served
7.2.5 Johnson Matthey PLC Recent Developments/Updates
7.3 Changzhou Pharmaceutical Factory
7.3.1 Changzhou Pharmaceutical Factory Lenalidomide API Corporation Information
7.3.2 Changzhou Pharmaceutical Factory Lenalidomide API Product Portfolio
7.3.3 Changzhou Pharmaceutical Factory Lenalidomide API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Changzhou Pharmaceutical Factory Main Business and Markets Served
7.3.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7.4 Shilpa Medicare Limited
7.4.1 Shilpa Medicare Limited Lenalidomide API Corporation Information
7.4.2 Shilpa Medicare Limited Lenalidomide API Product Portfolio
7.4.3 Shilpa Medicare Limited Lenalidomide API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Shilpa Medicare Limited Main Business and Markets Served
7.4.5 Shilpa Medicare Limited Recent Developments/Updates
7.5 Biocon Limited
7.5.1 Biocon Limited Lenalidomide API Corporation Information
7.5.2 Biocon Limited Lenalidomide API Product Portfolio
7.5.3 Biocon Limited Lenalidomide API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Biocon Limited Main Business and Markets Served
7.5.5 Biocon Limited Recent Developments/Updates
7.6 Sun Pharmaceutical Industries Ltd.
7.6.1 Sun Pharmaceutical Industries Ltd. Lenalidomide API Corporation Information
7.6.2 Sun Pharmaceutical Industries Ltd. Lenalidomide API Product Portfolio
7.6.3 Sun Pharmaceutical Industries Ltd. Lenalidomide API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
7.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.7 Shenzhen Haorui
7.7.1 Shenzhen Haorui Lenalidomide API Corporation Information
7.7.2 Shenzhen Haorui Lenalidomide API Product Portfolio
7.7.3 Shenzhen Haorui Lenalidomide API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Shenzhen Haorui Main Business and Markets Served
7.7.5 Shenzhen Haorui Recent Developments/Updates
7.8 Mac-Chem Products (India) Pvt.Ltd
7.8.1 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Corporation Information
7.8.2 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Product Portfolio
7.8.3 Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Mac-Chem Products (India) Pvt.Ltd Main Business and Markets Served
7.7.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Lenalidomide API Industry Chain Analysis
8.2 Lenalidomide API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lenalidomide API Production Mode & Process
8.4 Lenalidomide API Sales and Marketing
8.4.1 Lenalidomide API Sales Channels
8.4.2 Lenalidomide API Distributors
8.5 Lenalidomide API Customers
9 Lenalidomide API Market Dynamics
9.1 Lenalidomide API Industry Trends
9.2 Lenalidomide API Market Drivers
9.3 Lenalidomide API Market Challenges
9.4 Lenalidomide API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Lenalidomide API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Lenalidomide API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Lenalidomide API Production Capacity (Ton) by Manufacturers in 2023
Table 4. Global Lenalidomide API Production by Manufacturers (2019-2024) & (Ton)
Table 5. Global Lenalidomide API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Lenalidomide API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Lenalidomide API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Lenalidomide API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lenalidomide API as of 2023)
Table 10. Global Market Lenalidomide API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Lenalidomide API Production Sites and Area Served
Table 12. Manufacturers Lenalidomide API Product Types
Table 13. Global Lenalidomide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Lenalidomide API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Lenalidomide API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Lenalidomide API Production Value Market Share by Region (2019-2024)
Table 18. Global Lenalidomide API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Lenalidomide API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Lenalidomide API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Table 21. Global Lenalidomide API Production (Ton) by Region (2019-2024)
Table 22. Global Lenalidomide API Production Market Share by Region (2019-2024)
Table 23. Global Lenalidomide API Production (Ton) Forecast by Region (2025-2030)
Table 24. Global Lenalidomide API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Lenalidomide API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Lenalidomide API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Lenalidomide API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 28. Global Lenalidomide API Consumption by Region (2019-2024) & (Ton)
Table 29. Global Lenalidomide API Consumption Market Share by Region (2019-2024)
Table 30. Global Lenalidomide API Forecasted Consumption by Region (2025-2030) & (Ton)
Table 31. Global Lenalidomide API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Lenalidomide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 33. North America Lenalidomide API Consumption by Country (2019-2024) & (Ton)
Table 34. North America Lenalidomide API Consumption by Country (2025-2030) & (Ton)
Table 35. Europe Lenalidomide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 36. Europe Lenalidomide API Consumption by Country (2019-2024) & (Ton)
Table 37. Europe Lenalidomide API Consumption by Country (2025-2030) & (Ton)
Table 38. Asia Pacific Lenalidomide API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 39. Asia Pacific Lenalidomide API Consumption by Region (2019-2024) & (Ton)
Table 40. Asia Pacific Lenalidomide API Consumption by Region (2025-2030) & (Ton)
Table 41. Latin America, Middle East & Africa Lenalidomide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 42. Latin America, Middle East & Africa Lenalidomide API Consumption by Country (2019-2024) & (Ton)
Table 43. Latin America, Middle East & Africa Lenalidomide API Consumption by Country (2025-2030) & (Ton)
Table 44. Global Lenalidomide API Production (Ton) by Type (2019-2024)
Table 45. Global Lenalidomide API Production (Ton) by Type (2025-2030)
Table 46. Global Lenalidomide API Production Market Share by Type (2019-2024)
Table 47. Global Lenalidomide API Production Market Share by Type (2025-2030)
Table 48. Global Lenalidomide API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Lenalidomide API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Lenalidomide API Production Value Share by Type (2019-2024)
Table 51. Global Lenalidomide API Production Value Share by Type (2025-2030)
Table 52. Global Lenalidomide API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Lenalidomide API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Lenalidomide API Production (Ton) by Application (2019-2024)
Table 55. Global Lenalidomide API Production (Ton) by Application (2025-2030)
Table 56. Global Lenalidomide API Production Market Share by Application (2019-2024)
Table 57. Global Lenalidomide API Production Market Share by Application (2025-2030)
Table 58. Global Lenalidomide API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Lenalidomide API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Lenalidomide API Production Value Share by Application (2019-2024)
Table 61. Global Lenalidomide API Production Value Share by Application (2025-2030)
Table 62. Global Lenalidomide API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Lenalidomide API Price (US$/Ton) by Application (2025-2030)
Table 64. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Corporation Information
Table 65. Dr. Reddy’s Laboratories Ltd. Specification and Application
Table 66. Dr. Reddy’s Laboratories Ltd. Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
Table 68. Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
Table 69. Johnson Matthey PLC Lenalidomide API Corporation Information
Table 70. Johnson Matthey PLC Specification and Application
Table 71. Johnson Matthey PLC Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Johnson Matthey PLC Main Business and Markets Served
Table 73. Johnson Matthey PLC Recent Developments/Updates
Table 74. Changzhou Pharmaceutical Factory Lenalidomide API Corporation Information
Table 75. Changzhou Pharmaceutical Factory Specification and Application
Table 76. Changzhou Pharmaceutical Factory Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Changzhou Pharmaceutical Factory Main Business and Markets Served
Table 78. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 79. Shilpa Medicare Limited Lenalidomide API Corporation Information
Table 80. Shilpa Medicare Limited Specification and Application
Table 81. Shilpa Medicare Limited Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Shilpa Medicare Limited Main Business and Markets Served
Table 83. Shilpa Medicare Limited Recent Developments/Updates
Table 84. Biocon Limited Lenalidomide API Corporation Information
Table 85. Biocon Limited Specification and Application
Table 86. Biocon Limited Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Biocon Limited Main Business and Markets Served
Table 88. Biocon Limited Recent Developments/Updates
Table 89. Sun Pharmaceutical Industries Ltd. Lenalidomide API Corporation Information
Table 90. Sun Pharmaceutical Industries Ltd. Specification and Application
Table 91. Sun Pharmaceutical Industries Ltd. Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
Table 93. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 94. Shenzhen Haorui Lenalidomide API Corporation Information
Table 95. Shenzhen Haorui Specification and Application
Table 96. Shenzhen Haorui Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Shenzhen Haorui Main Business and Markets Served
Table 98. Shenzhen Haorui Recent Developments/Updates
Table 99. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Corporation Information
Table 100. Mac-Chem Products (India) Pvt.Ltd Specification and Application
Table 101. Mac-Chem Products (India) Pvt.Ltd Lenalidomide API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Mac-Chem Products (India) Pvt.Ltd Main Business and Markets Served
Table 103. Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates
Table 104. Key Raw Materials Lists
Table 105. Raw Materials Key Suppliers Lists
Table 106. Lenalidomide API Distributors List
Table 107. Lenalidomide API Customers List
Table 108. Lenalidomide API Market Trends
Table 109. Lenalidomide API Market Drivers
Table 110. Lenalidomide API Market Challenges
Table 111. Lenalidomide API Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lenalidomide API
Figure 2. Global Lenalidomide API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Lenalidomide API Market Share by Type: 2023 VS 2030
Figure 4. Purity≥98% Product Picture
Figure 5. Purity<98% Product Picture
Figure 6. Global Lenalidomide API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Lenalidomide API Market Share by Application: 2023 VS 2030
Figure 8. Lenalidomide capsules
Figure 9. Others
Figure 10. Global Lenalidomide API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Lenalidomide API Production Value (US$ Million) & (2019-2030)
Figure 12. Global Lenalidomide API Production Capacity (Ton) & (2019-2030)
Figure 13. Global Lenalidomide API Production (Ton) & (2019-2030)
Figure 14. Global Lenalidomide API Average Price (US$/Ton) & (2019-2030)
Figure 15. Lenalidomide API Report Years Considered
Figure 16. Lenalidomide API Production Share by Manufacturers in 2023
Figure 17. Lenalidomide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Lenalidomide API Revenue in 2023
Figure 19. Global Lenalidomide API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Lenalidomide API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Lenalidomide API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 22. Global Lenalidomide API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. India Lenalidomide API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. Europe Lenalidomide API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Lenalidomide API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Global Lenalidomide API Consumption by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 27. Global Lenalidomide API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. North America Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 29. North America Lenalidomide API Consumption Market Share by Country (2019-2030)
Figure 30. Canada Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 31. U.S. Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 32. Europe Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 33. Europe Lenalidomide API Consumption Market Share by Country (2019-2030)
Figure 34. Germany Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 35. France Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 36. U.K. Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 37. Italy Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 38. Russia Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 39. Asia Pacific Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 40. Asia Pacific Lenalidomide API Consumption Market Share by Regions (2019-2030)
Figure 41. China Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 42. Japan Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 43. South Korea Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 44. China Taiwan Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 45. Southeast Asia Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 46. India Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 47. Latin America, Middle East & Africa Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 48. Latin America, Middle East & Africa Lenalidomide API Consumption Market Share by Country (2019-2030)
Figure 49. Mexico Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 50. Brazil Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 51. Turkey Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 52. GCC Countries Lenalidomide API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 53. Global Production Market Share of Lenalidomide API by Type (2019-2030)
Figure 54. Global Production Value Market Share of Lenalidomide API by Type (2019-2030)
Figure 55. Global Lenalidomide API Price (US$/Ton) by Type (2019-2030)
Figure 56. Global Production Market Share of Lenalidomide API by Application (2019-2030)
Figure 57. Global Production Value Market Share of Lenalidomide API by Application (2019-2030)
Figure 58. Global Lenalidomide API Price (US$/Ton) by Application (2019-2030)
Figure 59. Lenalidomide API Value Chain
Figure 60. Lenalidomide API Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Lenalidomide API market?
The top companies in the global Lenalidomide API market are Dr. Reddy’s Laboratories Ltd.、Johnson Matthey PLC、Changzhou Pharmaceutical Factory.
Related Reports
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 126
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2026
The global Lenalidomide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 139
USD 4900.00
(Single User License)
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lenalidomide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 99
USD 3950.00
(Single User License)
Global Lenalidomide API Market Research Report 2025
The global market for Lenalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 95
USD 2900.00
(Single User License)
Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 77
USD 4250.00
(Single User License)
Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-04-15
Pages: 95
USD 4900.00
(Single User License)
Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published Date: 2024-02-23
Pages: 97
USD 3950.00
(Single User License)
Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lenalidomide API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 126
USD 3950.00 (Single User License)Global Lenalidomide API Market Research Report 2026
The global Lenalidomide API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
USD 2900.00 (Single User License)Global Lenalidomide API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lenalidomide API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 139
USD 4900.00 (Single User License)Lenalidomide API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lenalidomide API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 99
USD 3950.00 (Single User License)Global Lenalidomide API Market Research Report 2025
The global market for Lenalidomide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 95
USD 2900.00 (Single User License)Global Lenalidomide API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lenalidomide API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 77
USD 4250.00 (Single User License)Global Lenalidomide API Market Insights, Forecast to 2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-04-15
Pages: 95
USD 4900.00 (Single User License)Lenalidomide API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Thalidomide and its analogue lenalidomide are immunomodulatory and antineoplastic agents that are used in the therapy of multiple myeloma. Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.
Published: 2024-02-23
Pages: 97
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now